| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $14.45 ▲ +1.15% | Yesterday | $14.22 ▼ -0.48% | Tomorrow's Avalo Therapeutics Inc. Common Stock (AVTX) setup is anchored to $14.29 and targets $14.45 (+1.15%). The near-term read is upside; watch $14.72 / $13.86 because daily realized volatility is about 5.93%. |
Tomorrow's Avalo Therapeutics Inc. Common Stock (AVTX) setup is anchored to $14.29 and targets $14.45 (+1.15%). The near-term read is upside; watch $14.72 / $13.86 because daily realized volatility is about 5.93%. | ||||
| Week | $14.80 ▲ +3.58% | Last Week | $14.08 ▼ -1.50% | The 7-day Avalo Therapeutics Inc. Common Stock model moves from $14.08 to $14.80 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.72 / $13.86 matter more than a single tick. |
The 7-day Avalo Therapeutics Inc. Common Stock model moves from $14.08 to $14.80 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.72 / $13.86 matter more than a single tick. | ||||
| Month | $15.38 ▲ +7.61% | Last Month | $13.83 ▼ -3.20% | The 1-month Avalo Therapeutics Inc. Common Stock target is $15.38 (+7.61%), compared with the live reference near $14.29. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Avalo Therapeutics Inc. Common Stock target is $15.38 (+7.61%), compared with the live reference near $14.29. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $16.24 ▲ +13.67% | Last Year | $13.47 ▼ -5.74% | The 1-year Avalo Therapeutics Inc. Common Stock scenario points to $16.24 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Avalo Therapeutics Inc. Common Stock scenario points to $16.24 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $18.27 ▲ +27.86% | 5 Years Ago | $12.62 ▼ -11.70% | The 5-year Avalo Therapeutics Inc. Common Stock view is $18.27 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Avalo Therapeutics Inc. Common Stock view is $18.27 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $14.29 | Mid |
| Daily Change | -2.52% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $14.29 | Daily Change | -2.52% |
| Market Cap | $381.75M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.